![Abhinav Jain](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Abhinav Jain
Director/Board Member at
AYTU BIOPHARMA, INC.
Net worth: 123 960 $ as of 30/05/2026
Profile
Mr. Abhinav Jain is an Independent Director at Eagle Pharmaceuticals, Inc., an Independent Director at Talphera, Inc. and an Independent Director at Aytu Biopharma, Inc. He is on the Board of Directors at Eagle Pharmaceuticals, Inc., Xtant Medical Holdings, Inc., Talphera, Inc. and Aytu Biopharma, Inc. Mr. Jain was previously employed as an Associate by Angelo, Gordon & Co. LP.
He received his undergraduate degree from Massachusetts Institute of Technology and an MBA from The Wharton School of the University of Pennsylvania.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 14/11/2025 | 158,228 ( 0.11% ) | 73 101 $ | 30/05/2026 | |
AYTU BIOPHARMA, INC. 0.18% | 12/10/2025 | 19,500 ( 0.18% ) | 44 655 $ | 30/05/2026 |
TALPHERA, INC. 0.02% | 23/04/2026 | 7,602 ( 0.02% ) | 6 203 $ | 30/05/2026 |
Abhinav Jain active positions
| Companies | Position | Start |
|---|---|---|
| AYTU BIOPHARMA, INC. | Director/Board Member | 11/06/2023 |
| TALPHERA, INC. | Director/Board Member | 21/01/2024 |
| XTANT MEDICAL HOLDINGS, INC. | Director/Board Member | 31/07/2025 |
| EAGLE PHARMACEUTICALS, INC. | Director/Board Member | 27/08/2025 |
Former positions of Abhinav Jain
| Companies | Position | End |
|---|---|---|
Angelo, Gordon & Co. LP
 Angelo, Gordon & Co. LP Investment ManagersFinance TPG Angelo Gordon seeks alternative investment opportunities that will deliver consistent absolute returns for their clients. The firm manages capital across their Credit and Real Estate strategies, all of which employ a disciplined investment philosophy that combines fundamental in-depth research with a diversification strategy 20 designed to reduce downside risk. The research team is the cornerstone of all investment activities. | Corporate Officer/Principal | 31/12/2016 |
Training of Abhinav Jain
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
63
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Angelo, Gordon & Co. LP
Angelo, Gordon & Co. LP Investment ManagersFinance TPG Angelo Gordon seeks alternative investment opportunities that will deliver consistent absolute returns for their clients. The firm manages capital across their Credit and Real Estate strategies, all of which employ a disciplined investment philosophy that combines fundamental in-depth research with a diversification strategy 20 designed to reduce downside risk. The research team is the cornerstone of all investment activities. | Finance |
Eagle Pharmaceuticals, Inc.
 Eagle Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercialize injectable products primarily in the metabolic critical care and oncology | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Talphera, Inc.
 Talphera, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aytu Biopharma, Inc.
 Aytu Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Xtant Medical Holdings, Inc.
 Xtant Medical Holdings, Inc. Medical SpecialtiesHealth Technology Manufactures and commercializes surgical products | Health Technology |
- Stock Market
- Insiders
- Abhinav Jain
